跳至主要内容
临床试验/NCT02980978
NCT02980978已完成不适用

diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED)

Minneapolis Heart Institute Foundation0 个研究点目标入组 118 人开始时间: 2016年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
118
主要终点
A1c (Laboratory Assessment)

研究概览

简要总结

This study aims to randomly assign individuals with type 2 diabetes into the ENHANCED randomized control trial. The study is being conducted by the Minneapolis Heart Institute Foundation (MHIF) and will have two study sites 1) Hutchinson Health and 2) New Ulm Medical Center. The study is primarily funded through the Academy of Nutrition and Dietetics (AND).

The study will examine the impact of a registered dietitian-led, primary care integrated, telemedicine program on diabetes care measures (the 'D5') over one year as compared to usual care. The D5 goals include: blood pressure <140/90 mmHg, taking a statin as appropriate, A1c <8%, not using tobacco and taking an aspirin as appropriate.

详细描述

Individuals will be invited to attend a baseline visit where they will have lab work done, anthropometrics (height, weight, waist circumference) and complete a lifestyle assessment. They will formally consent to participation by signing a study consent form. The same measures will be collected after completion of the one year study.

Study participants will receive two sessions of free lab work, a diabetes education book, and brief coaching with a registered dietitian/certified diabetes educator. In addition, those randomized to the phone coaching will have access to a registered dietitian/certified diabetes educator on a monthly basis for one year of personalized health coaching for free. The intent of this coaching is to help individuals achieve diabetes "optimal" care or meeting all 5 Diabetes Care measures (blood glucose, blood pressure, tobacco use, statin and aspirin use).

This program is designed to complement usual clinic-based primary care, with coaches documenting lab, biometrics and medication adjustments in the EHR, along with documenting phone encounters and communicating directly with patients' PCPs as needed. Documentation in the EHR uses an order created specifically for the study indicating the patient's research status.

Lab work required as part of this research study at baseline and 12 months is covered by the study. Any lab work and/or medication co-pays or fees outside of the baseline and 12 month study visits are the responsibility of the patient and/or their insurance

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Type 2 Diabetes
  • Individuals who are not meeting 3 or more D5 goals,
  • Have had a visit with a provider within the last 2 years

排除标准

  • Type 1 Diabetes
  • Chronic kidney disease (GFR <30)
  • Institutional residence
  • Major cognitive or language barrier (as determined by program enrollment staff)
  • Other active end-stage disease (e.g., late stage cancer or pulmonary disease)
  • Actively receiving cancer treatment

研究组 & 干预措施

Intervention

Experimental

Individuals assigned to the intervention group will have supplemental care provided by a registered dietitian/certified diabetes educator which includes counseling on lifestyle to improve diabetes and overall health. Additionally, individuals in this group may be started on medications (or adjustments to current medications) for blood pressure, cholesterol or blood glucose to meet diabetes care goals

干预措施: Coaching (Behavioral)

Standard of Care

No Intervention

Individuals will be followed by their Primary Care Provider as standard of care and per usual clinical need

结局指标

主要结局

A1c (Laboratory Assessment)

时间窗: 1 year

The count of participants represents the number of individuals meeting A1c less than 8% at follow up

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验